Publications by authors named "Anca D Askanase"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

4,868

Total Likes

285

Extended Reach

3,459,256

Social Features

152
T
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Eric F Morand, Richard Furie, Yoshiya Tanaka, Ian N Bruce, Anca D Askanase, Christophe Richez, Sang-Cheol Bae, Philip Z Brohawn, Lilia Pineda, Anna Berglind

N Engl J Med· January 2020

Videos about Article: user

1 1 6 150 1 3 15 3

View All Article and Social Media Activity
N
New efforts to incorporate patient-reported outcomes into lupus clinical trials: report of the community meeting convened by the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), 16-17 October 2024.
Patricia Katz, Anca D Askanase, Nandan Baruah, Wen-Hung Chen, Anna Fisch

Lupus Sci Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis.
Despina Michailidou, Yevgeniya Gartshteyn, Anca D Askanase, Andras Perl

Autoimmun Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus.
Cristina Arriens, Eric F Morand, Anca D Askanase, Richard Furie, Ronald F van Vollenhoven

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, Jeffrey A Cohen, Zachary S Wallace, Anca D Askanase

JCI Insight· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective.
Elena W Y Hsieh, James B Chung, Afsah Amin, Anca D Askanase, Beatrix Bartok

RMD Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a minimal core dataset for systemic lupus erythematosus studies.
Stephen McDonald, Jialin Teng, Chengde Yang, Michelle Barraclough, Graciela S Alarcon, Anca D Askanase

Lupus Sci Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.
Wils Nielsen, Fadi Kharouf, Carolina Munoz Grajales, Aarabi Thayaparan, Melanie Anderson, Anca D Askanase

Semin Arthritis Rheum· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents.
Anca D Askanase, Richard Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting

Rheumatol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study.
Kathryn Connelly, Rachel Koelmeyer, Darshini Ayton, John May, Kate Gregory, Anca D Askanase

Lupus Sci Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials.
Anca D Askanase, Edward M Vital, Oliver Meier, Armando Turchetta, Huiyan Ashley Mao

Lupus Sci Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, Jeffrey A Cohen, Zachary S Wallace, Anca D Askanase

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial.
Anca D Askanase, David D'Cruz, Kenneth Kalunian, Joan T Merrill, Sandra V Navarra

Lancet Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS.
Maria Dall'Era, Kenneth Kalunian, Neil Solomons, Matt Truman, Lucy S Hodge, Anca D Askanase

Lupus Sci Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations.
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting

Lupus Sci Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis.
Yevgeniya Gartshteyn, Laura Geraldino-Pardilla, Leila Khalili, Shoiab Bukhari, Shalom Lerrer, Anca D Askanase

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus.
Yevgeniya Gartshteyn, John Conklin, Michelle A Petri, Vasileios C Kyttaris, Daniel W Goldman, Anca D Askanase

Arthritis Care Res (Hoboken)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lupus clinical trials and the promise of future therapies.
Leila Khalili, Wei Tang, Anca D Askanase

Rheumatol Immunol Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE.
Anca D Askanase, Cynthia Aranow, Mimi Y Kim, Diane L Kamen, Cristina Arriens

Lupus Sci Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving resource utilisation in SLE drug development through innovative trial design.
Sandra Garces, Elaine Karis, Joan T Merrill, Anca D Askanase, Kenneth Kalunian

Lupus Sci Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE.
Anca D Askanase, Wei Tang, Qing Zuraw, Robert Gordon, Betsy Brotherton

Lupus Sci Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases.
Rosaria Talarico, Anca D Askanase, Maurizio Cutolo

Front Med (Lausanne)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLAMF6 compartmentalization enhances T cell functions.
Yevgeniya Gartshteyn, Anca D Askanase, Ruijiang Song, Shoiab Bukhari, Matthew Dragovich

Life Sci Alliance· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective.
Joy Buie, Lauren Bloch, Eric F Morand, Ronald F van Vollenhoven, Victoria P Werth, Anca D Askanase

Lupus Sci Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine.
Celline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Anca D Askanase

Lupus Sci Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic.
Francesca S Cardwell, Susan J Elliott, Ricky Chin, Yvan St Pierre, May Y Choi, Anca D Askanase

Lupus Sci Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis